Gee‐Hong Kuo

1.2k total citations
46 papers, 1.0k citations indexed

About

Gee‐Hong Kuo is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Gee‐Hong Kuo has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Organic Chemistry and 8 papers in Surgery. Recurrent topics in Gee‐Hong Kuo's work include Peroxisome Proliferator-Activated Receptors (8 papers), Receptor Mechanisms and Signaling (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Gee‐Hong Kuo is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Receptor Mechanisms and Signaling (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Gee‐Hong Kuo collaborates with scholars based in United States, Belgium and Norway. Gee‐Hong Kuo's co-authors include Keith T. Demarest, William V. Murray, Harry H. Wasserman, Thomas A. Rano, Patricia D. Pelton, Jun Xu, Catherine Prouty, Linda K. Jolliffe, Ellen Sieber-McMaster and Maria Yang and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gee‐Hong Kuo

43 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gee‐Hong Kuo United States	22	540	486	134	106	101	46	1.0k
Samuel Chackalamannil United States	24	848 1.6×	504 1.0×	60 0.4×	75 0.7×	59 0.6×	75	1.7k
John K. Dickson United States	17	351 0.7×	499 1.0×	124 0.9×	232 2.2×	85 0.8×	34	1.1k
Raju Mohan United States	19	579 1.1×	647 1.3×	60 0.4×	107 1.0×	73 0.7×	35	1.3k
Takehiko Naka Japan	19	621 1.1×	733 1.5×	229 1.7×	41 0.4×	76 0.8×	38	1.5k
Claudio F. Sturino Canada	18	644 1.2×	355 0.7×	76 0.6×	89 0.8×	32 0.3×	29	1.1k
Xian‐Yun Jiao United States	14	301 0.6×	369 0.8×	106 0.8×	129 1.2×	34 0.3×	22	704
Brajendra K. Tripathi United States	14	324 0.6×	458 0.9×	189 1.4×	72 0.7×	22 0.2×	32	1.0k
Harold B. Wood United States	19	271 0.5×	613 1.3×	86 0.6×	54 0.5×	68 0.7×	38	950
Deirdre M. B. Hickey United Kingdom	20	387 0.7×	516 1.1×	168 1.3×	382 3.6×	50 0.5×	40	1.3k
David R. Magnin United States	14	367 0.7×	332 0.7×	46 0.3×	81 0.8×	69 0.7×	21	736

Countries citing papers authored by Gee‐Hong Kuo

Since Specialization

Citations

This map shows the geographic impact of Gee‐Hong Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gee‐Hong Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gee‐Hong Kuo more than expected).

Fields of papers citing papers by Gee‐Hong Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gee‐Hong Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gee‐Hong Kuo. The network helps show where Gee‐Hong Kuo may publish in the future.

Co-authorship network of co-authors of Gee‐Hong Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Gee‐Hong Kuo. A scholar is included among the top collaborators of Gee‐Hong Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gee‐Hong Kuo. Gee‐Hong Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Guozhang, Fuyong Du, Gee‐Hong Kuo, et al.. (2020). 5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(17). 127387–127387. 10 indexed citations

Kuo, Gee‐Hong, Micheal D. Gaul, Yin Liang, et al.. (2018). Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(7). 1182–1187. 29 indexed citations

Du, Fuyong, Simon A. Hinke, Cassandre Cavanaugh, et al.. (2018). Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents. Journal of Pharmacology and Experimental Therapeutics. 365(3). 676–687. 25 indexed citations

Qi, Jenson, John A. Masucci, Wensheng Lang, et al.. (2017). Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors. SLAS DISCOVERY. 22(4). 433–439.

Qi, Jenson, Wensheng Lang, Margery A. Connelly, et al.. (2016). Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo. Analytical Biochemistry. 524. 68–75. 1 indexed citations

Yang, Shyh‐Ming, Yuting Tang, Thomas A. Rano, et al.. (2014). 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: Part 2. Pyridazine-based analogs. Bioorganic & Medicinal Chemistry Letters. 24(5). 1437–1441. 6 indexed citations

Zhang, Xuqing, Gee‐Hong Kuo, Alan C. Gibbs, et al.. (2011). Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(16). 4762–4767. 20 indexed citations

Connelly, Margery A., Tom J. Parry, Edward C. Giardino, et al.. (2010). Torcetrapib Produces Endothelial Dysfunction Independent of Cholesteryl Ester Transfer Protein Inhibition. Journal of Cardiovascular Pharmacology. 55(5). 459–468. 30 indexed citations

Wang, Aihua, Catherine Prouty, Patricia D. Pelton, et al.. (2010). Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(4). 1432–1435. 34 indexed citations

10.

Zhang, Rui, Aihua Wang, Ellen Sieber-McMaster, et al.. (2009). Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 19(4). 1101–1104. 8 indexed citations

11.

Shen, Lan, Yan Zhang, Aihua Wang, et al.. (2007). Synthesis and structure–activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists. Bioorganic & Medicinal Chemistry. 16(6). 3321–3341. 21 indexed citations

12.

Zhang, Rui, Aihua Wang, Patricia D. Pelton, et al.. (2007). Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3855–3859. 23 indexed citations

13.

Wu, W. N., L. A. McKown, & Gee‐Hong Kuo. (2006). Hepatic metabolism of two α-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human. European Journal of Drug Metabolism and Pharmacokinetics. 31(4). 271–276. 2 indexed citations

14.

Wu, W. N., L. A. McKown, & Gee‐Hong Kuo. (2005). Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats. European Journal of Drug Metabolism and Pharmacokinetics. 30(1-2). 113–120. 3 indexed citations

15.

O’Neill, David J., Lan Shen, Catherine Prouty, et al.. (2004). Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors. Bioorganic & Medicinal Chemistry. 12(12). 3167–3185. 41 indexed citations

16.

Zhang, Han‐Cheng, Hong Ye, Barbara R. Conway, et al.. (2004). 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3. Bioorganic & Medicinal Chemistry Letters. 14(12). 3245–3250. 57 indexed citations

17.

Kuo, Gee‐Hong, Catherine Prouty, Lan Shen, et al.. (2003). Synthesis and Discovery of Macrocyclic Polyoxygenated Bis-7-azaindolylmaleimides as a Novel Series of Potent and Highly Selective Glycogen Synthase Kinase-3β Inhibitors. Journal of Medicinal Chemistry. 46(19). 4021–4031. 72 indexed citations

18.

Khatuya, Haripada, R. H. Hutchings, Gee‐Hong Kuo, et al.. (2002). Arylpiperazine substituted heterocycles as Selective α1a adrenergic antagonists. Bioorganic & Medicinal Chemistry Letters. 12(17). 2443–2446. 11 indexed citations

19.

Eissenstat, Michael A., Gee‐Hong Kuo, John D. Weaver, et al.. (1995). 3-benzyl-quinolones: Novel, potent inhibitors of mammalian topoisomerase II. Bioorganic & Medicinal Chemistry Letters. 5(9). 1021–1026. 13 indexed citations

20.

Singh, B. N., Edward R. Bacon, Shaughnessy Robinson, et al.. (1994). Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogs. Journal of Medicinal Chemistry. 37(2). 248–254. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact